We are live on ! Find out more
HALO icon

Halozyme

161 hedge funds and large institutions have $909M invested in Halozyme in 2016 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 59 increasing their positions, 50 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

359% more call options, than puts

Call options by funds: $14M | Put options by funds: $3.04M

18% more repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 50

0% more funds holding

Funds holding: 161161 (0)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 18

6% less capital invested

Capital invested by funds: $967M → $909M (-$57.7M)

Holders
161
Holders Change
Holders Change %
0%
% of All Funds
4.3%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
18
Increased
59
Reduced
50
Closed
18
Calls
$14M
Puts
$3.04M
Net Calls
+$10.9M
Net Calls Change
-$5.71M
Name Holding Trade Value Shares
Change
Change in
Stake
Fisher Asset Management
26
Fisher Asset Management
Washington
$6.58M +$170K +17,231 +2%
TA
27
Teachers Advisors
New York
$6.23M +$156K +15,823 +2%
Macquarie Group
28
Macquarie Group
Australia
$5.26M +$3.01M +304,800 +100%
CS
29
Credit Suisse
Switzerland
$4.36M -$231K -23,395 -4%
QF
30
QVT Financial
New York
$4.32M -$1.91M -193,987 -28%
FAM
31
Fred Alger Management
New York
$3.73M +$174K +17,583 +4%
OAM
32
Oxford Asset Management
United Kingdom
$3.59M -$138K -13,964 -3%
BIM
33
BlackRock Investment Management
Delaware
$3.5M +$355K +35,975 +10%
New York State Common Retirement Fund
34
New York State Common Retirement Fund
New York
$3.3M +$23.5K +2,380 +0.6%
Charles Schwab
35
Charles Schwab
California
$3.23M -$664K -67,293 -15%
Millennium Management
36
Millennium Management
New York
$3.2M +$768K +77,857 +27%
Morgan Stanley
37
Morgan Stanley
New York
$3.07M +$581K +58,850 +20%
Goldman Sachs
38
Goldman Sachs
New York
$3.03M +$179K +18,100 +5%
TCIM
39
TIAA CREF Investment Management
New York
$2.95M -$201K -20,414 -6%
BG
40
Bellevue Group
Switzerland
$2.74M
Brown Advisory
41
Brown Advisory
Maryland
$2.3M +$2.04M +206,585 +343%
GC
42
Guggenheim Capital
Illinois
$2.19M -$141K -14,243 -5%
RPAM
43
Rhenman & Partners Asset Management
Sweden
$2.16M -$1.79M -181,000 -42%
BA
44
BlackRock Advisors
Delaware
$1.98M +$25.8K +2,611 +1%
California State Teachers Retirement System (CalSTRS)
45
California State Teachers Retirement System (CalSTRS)
California
$1.97M +$32.2K +3,260 +1%
SEI Investments
46
SEI Investments
Pennsylvania
$1.93M +$44.6K +4,515 +2%
UBS Group
47
UBS Group
Switzerland
$1.91M +$201K +20,403 +10%
Allianz Asset Management
48
Allianz Asset Management
Germany
$1.86M +$1.09M +110,520 +105%
California Public Employees Retirement System
49
California Public Employees Retirement System
California
$1.83M -$65.1K -6,600 -3%
CS
50
Candriam SCA
Luxembourg
$1.74M -$296K -30,000 -13%

HALO Hedge Fund Activity: Q2 2016 in Review

161 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Halozyme (HALO) for Q2 2016, worth a combined $909M — down 6% from $967M a quarter earlier.

Fund positioning in HALO was balanced in Q2 2016: 18 funds opened new positions, 18 closed out, 59 added to existing stakes and 50 trimmed.

The largest buyer was Bank of New York Mellon, adding an estimated $17.6M. The largest seller was Invesco, cutting an estimated $9.18M.

  • 161 institutional investors held Halozyme (HALO) as of Q2 2016, unchanged from Q1 2016.
  • Funds reported $909M of Halozyme stock for Q2 2016, down 6% quarter-over-quarter.
  • 18 funds opened new Halozyme positions in Q2 2016 and 18 closed out, a net change of 0 holders.
  • The largest Halozyme buyer in Q2 2016 was Bank of New York Mellon, an estimated $17.6M added.
  • The largest Halozyme seller in Q2 2016 was Invesco, an estimated $9.18M sold.

Based on aggregated 13F filings for Q2 2016.